In vitro synergistic activities of antimicrobial peptide brevinin-2CE with five kinds of antibiotics against multidrug-resistant clinical isolates

Current Microbiology

Volumn 68, Issue 6, 2014, Pages 685-692

  Zhang, Yuan ^a   Liu, Yukun ^a   Sun, Yan ^a   Liu, Qingmei ^a   Wang, Xiaoyan ^a   Li, Zhi ^a   Hao, Jie ^a  

^a SHAANXI NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIBIAN PROTEINS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; ESCHERICHIA COLI; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS;

EID: 84898922091     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-014-0529-4     Document Type: Article

References (30)

1. Al-Ghaferi N, Kolodziejek J, Nowotny N, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD, Conlon JM (2010) Antimicrobial peptides from the skin secretions of the South-East Asian frog Hylarana erythraea (Ranidae). Peptides 31(4):548-554. doi: 10.1016/j.peptides.2009.12.013
2. Baranska-Rybak W, Cirioni O, Dawgul M, Sokolowska-Wojdylo M, Naumiuk L, Szczerkowska-Dobosz A, Nowicki R, Roszkiewicz J, Kamysz W (2011) Activity of antimicrobial peptides and conventional antibiotics against superantigen positive Staphylococcus aureus isolated from the patients with neoplastic and inflammatory erythrodermia. Chemother Res Pract 2011:270932. doi: 10.1155/2011/270932
3. Bevins CL, Zasloff M (1990) Peptides from frog skin. Annu Rev Biochem 59:395-414. doi: 10.1146/annurev.bi.59.070190.002143
4. Borde JP, Kern WV (2012) Treatment of MRSA infections. Dtsch Med Wochenschr 137(49):2553-2557. doi: 10.1055/s-0032-1327283
5. Cassone M, Vogiatzi P, La Montagna R, De Olivier Inacio V, Cudic P, Wade JD, Otvos L Jr (2008) Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics. Peptides 29(11):1878-1886. doi: 10.1016/j.peptides.2008.07.016
6. Conlon JM, Al-Ghaferi N, Abraham B, Sonnevend A, Coquet L, Leprince J, Jouenne T, Vaudry H, Iwamuro S (2006) Antimicrobial peptides from the skin of the Tsushima brown frog Rana tsushimensis. Comp Biochem Physiol Toxicol Pharmacol 143(1):42-49. doi: 10.1016/j.cbpc.2005.11.022
7. Conlon JM, Ahmed E, Condamine E (2009) Antimicrobial properties of brevinin-2-related peptide and its analogs: efficacy against multidrug-resistant Acinetobacter baumannii. Chem Biol Drug Des 74(5):488-493. doi: 10.1111/j.1747-0285.2009.00882.x
8. Desbois AP, Gemmell CG, Coote PJ (2010) In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic methicillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 35(6):559-565. doi: 10.1016/j.ijantimicag.2010.01.016
9. Giacometti A, Cirioni O, Barchiesi F, Scalise G (2000) In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics. Diagn Microbiol Infect Dis 38(2):115-118
10. He K, Ludtke SJ, Huang HW, Worcester DL (1995) Antimicrobial peptide pores in membranes detected by neutron in-plane scattering. Biochemistry 34(48):15614-15618
11. Hossain MA, Guilhaudis L, Sonnevend A, Attoub S, van Lierop BJ, Robinson AJ, Wade JD, Conlon JM (2011) Synthesis, conformational analysis and biological properties of a dicarba derivative of the antimicrobial peptide, brevinin-1BYa. Eur Biophys J 40(4):555-564. doi: 10.1007/s00249-011-0679-2
12. Huang HW (1999) Peptide-lipid interactions and mechanisms of antimicrobial peptides. Novartis Found Symp 225:188-200 discussion 200-186
13. Huang HW, Wu Y (1991) Lipid-alamethicin interactions influence alamethicin orientation. Biophys J 60(5):1079-1087
14. Jiang Y, Yi X, Li M, Wang T, Qi T, She X (2012) Antimicrobial activities of recombinant mouse beta-defensin 3 and its synergy with antibiotics. J Mater Sci Mater Med 23(7):1723-1728. doi: 10.1007/s10856-012-4645-z
15. Lee BS, Hwang JH, Lee SH, Jang SE, Jang ES, Jo HJ, Shin CM, Park YS, Kim JW, Jung SH, Kim N, Lee DH, Lee JK, Ahn S (2012) Risk factors of organ failure in patients with bacteremic cholangitis. Dig Dis Sci. doi: 10.1007/s10620-012- 2478-8
16. Li Q, Huang J, Guo H, Guo X, Zhu Y, Dong K (2012) Bactericidal activity against meticillin-resistant Staphylococcus aureus of a novel eukaryotic therapeutic recombinant antimicrobial peptide. Int J Antimicrob Agents 39(6):496-499. doi: 10.1016/j.ijantimicag.2012.03.003
17. Lin MC, Hui CF, Chen JY, Wu JL (2013) Truncated antimicrobial peptides from marine organisms retain anticancer activity and antibacterial activity against multidrug-resistant Staphylococcus aureus. Peptides 44:139-148. doi: 10.1016/j.peptides.2013.04.004
18. Lu Z, Zhai L, Wang H, Che Q, Wang D, Feng F, Zhao Z, Yu H (2010) Novel families of antimicrobial peptides with multiple functions from skin of Xizang plateau frog, Nanorana parkeri. Biochimie 92(5):475-481. doi: 10.1016/j.biochi.2010.01.025
19. Ludtke SJ, He K, Wu Y, Huang HW (1994) Cooperative membrane insertion of magainin correlated with its cytolytic activity. Biochim Biophys Acta 1190(1):181-184
20. Morikawa N, Hagiwara K, Nakajima T (1992) Brevinin-1 and -2, unique antimicrobial peptides from the skin of the frog, Rana brevipoda porsa. Biochem Biophys Res Commun 189(1):184-190
21. Nicolas P, Vanhoye D, Amiche M (2003) Molecular strategies in biological evolution of antimicrobial peptides. Peptides 24(11):1669-1680. doi: 10.1016/j.peptides.2003.08.017
22. Nuotio L, Schneitz C, Nilsson O (2013) Effect of competitive exclusion in reducing the occurrence of Escherichia coli producing extended-spectrum beta-lactamases in the ceca of broiler chicks. Poult Sci 92(1):250-254. doi: 10.3382/ps.2012-02575
23. Rennie RP (2012) Current and future challenges in the development of antimicrobial agents. Handb Exp Pharmacol 211:45-65. doi: 10.1007/978-3-642- 28951-4-4
24. Rishi P, Preet S, Bharrhan S, Verma I (2011) In vitro and in vivo synergistic effects of cryptdin 2 and ampicillin against Salmonella. Antimicrob Agents Chemother 55(9):4176-4182. doi: 10.1128/AAC.00273-11
25. Schroppel K, Riessen R (2013) Multiresistant gram-negative bacteria: a bacterial challenge of the twenty-first century. Medizinische Klinik Intensivmedizin und Notfallmedizin. doi: 10.1007/s00063-012-0160-8
26. Sueke H, Kaye SB, Neal T, Hall A, Tuft S, Parry CM (2010) An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci 51(8):4151-4155. doi: 10.1167/iovs.09-4839
27. Wayne (2012) Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 9th edn, Approved standard M07-A9
28. Wu Y, He K, Ludtke SJ, Huang HW (1995) X-ray diffraction study of lipid bilayer membranes interacting with amphiphilic helical peptides: diphytanoyl phosphatidylcholine with alamethicin at low concentrations. Biophys J 68(6):2361-2369. doi: 10.1016/S0006-3495(95)80418-2
29. Yang Y, Liu H, Liu G, Ran X (2010) Antibacterial effect of autologous platelet-rich gel derived from health volunteers in vitro. Zhongguo xiu fu chong jian wai ke za zhi 24(5):571-576
30. Zhao J, Sun Y, Li Z, Su Q (2011) Molecular cloning of novel antimicrobial peptide genes from the skin of the Chinese brown frog, Rana chensinensis. Zoolog Sci 28(2):112-117. doi: 10.2108/zsj.28.112